- World rank, 2022-now
- #20,077 of 22,385
- Rank in United States
- #2,969 of 3,332
- Research works
- 103 ▲ 203% vs 2018-21
- Citations
- 2.8k 26.8 per fractional work
- Top-10% rate
- 24.1% all institutions 10.0%
- vs its own fields
- 1.02× 1.00× is exactly expected
- Open access
- 48% world 40%
- International
- 12% world 18%
Which fields of science does Mirati Therapeutics (United States) work in?
In 2022-now, 42% of research at Mirati Therapeutics (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (38%), Medicine (36%), Chemistry (14%). It does 2.6× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 15 fields, with their numbers
- Life Sciences2842.2%
- Health Sciences2436.4%
- Medicine2436.4%
- Nursing00.1%
- Health Professions00.0%
- Physical Sciences1320.2%
- Chemistry914.0%
- Engineering12.2%
- Materials Science11.8%
- Computer Science11.5%
- Mathematics00.5%
- Environmental Science00.1%
- Social Sciences11.2%
What does Mirati Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 10.2× the share of its output that it takes of world research.
- Molecular BiologySubfield · 20.4 works10×
- Biochemistry, Genetics and Molecular BiologyField · 25.1 works7.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 8.9×. Every wedge is a field page.
All 14 fields, with their numbers
- Chemistry8.92×9 works
- Biochemistry, Genetics and Molecular Biology7.09×25 works
- Pharmacology, Toxicology and Pharmaceutics6.07×1 works
- Medicine1.89×24 works
- Immunology and Microbiology1.53×1 works
- Economics, Econometrics and Finance0.56×1 works
- Materials Science0.53×1 works
- Mathematics0.43×0 works
- Neuroscience0.39×0 works
- Computer Science0.20×1 works
- Engineering0.15×1 works
- Nursing0.11×0 works
- Environmental Science0.03×0 works
- Health Professions0.01×0 works
- Chemistry 8.9×
- Biochemistry, Genetics and Molecular Biology 7.1×
- Pharmacology, Toxicology and Pharmaceutics 6.1×
- Medicine 1.9×
- Immunology and Microbiology 1.5×
- Economics, Econometrics and Finance 0.6×
- Materials Science 0.5×
- Mathematics 0.4×
- Neuroscience 0.4×
- Computer Science 0.2×
- Engineering 0.1×
- Nursing 0.1×
- Environmental Science 0.0×
- Health Professions 0.0×
Who are the top researchers at Mirati Therapeutics (United States)?
Ranked on the quality score, Jill F. Hallin, Peter Olson and David M. Briere lead among researchers whose main affiliation is Mirati Therapeutics (United States).
- 1
Jill F. Hallin
United States · #16,868 worldwide 5.9k citations · 361 works
- 2
Peter Olson
United States · #34,939 worldwide 15k citations · 274 works
- 3
David M. Briere
United States · #55,570 worldwide 4.9k citations · 207 works
- 4
Lars D. Engstrom
United States · #69,789 worldwide 4.6k citations · 183 works
- 5
Karen Velastegui
United States · #147,039 worldwide 3.1k citations · 126 works
- 6
Hirak Der‐Torossian
United States · #170,662 worldwide 3k citations · 195 works
- 7
Niranjan Sudhakar
United States · #184,352 worldwide 2.8k citations · 100 works
- 8
Laura D. Hover
United States · #214,063 worldwide 1.1k citations · 137 works
- 9
Andrew Calinisan
United States · #214,419 worldwide 3k citations · 98 works
- 10
J. David Lawson
United States · #321,349 worldwide 8.6k citations · 146 works
Which keywords describe research at Mirati Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Cell Proliferation, Chemotherapy, Clinical Trials, Epigenetic Regulation, Arginine Methylation and Protein Arginine Methyltransferases.
- Ras Signaling
- PD-1 and PD-L1
- Enantioselective Reactions
- Cell Migration
- Amination
- Mutation
- Prognostic Factors
- KRAS Mutations
- Synthesis
- Enantioselective
- Foldamers
- EGFR Mutations
- Inflammation
- Genomic Profiling
- Immunotherapy
- Cancer Therapy
- Protein Arginine Methyltransferases
- Arginine Methylation
- Chemotherapy
- Transcriptional Regulation
- Cancer
- Cell Proliferation
- Clinical Trials
- Epigenetic Regulation
- Targeted Therapy
- Tumor Microenvironment
- Drug Discovery
- Medicinal Chemistry
- ALK Inhibitors
- Protein-Protein Interactions
- Peptide Synthesis
- Precision Medicine
- Cetuximab
- Oncogenic Mutations
- Cell Signaling
- Therapeutic Targets
- Catalytic
- Chiral Ligands
- Immune Checkpoint Blockade
- Protein Kinases
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer11▲ 12×16 topics
- Transcriptional Regulation8▲ 72×5 topics
- Cell Proliferation6▲ 111×3 topics
- Chemotherapy6▲ 12×8 topics
- Clinical Trials6▲ 13×7 topics
- Arginine Methylation6▲ 328×1 topic
- Epigenetic Regulation6▲ 41×2 topics
- Protein Arginine Methyltransferases6▲ 328×1 topic
- Targeted Therapy5▲ 36×4 topics
- Cancer Therapy5▲ 14×9 topics
- Tumor Microenvironment5▲ 17×7 topics
- Immunotherapy5▲ 10×11 topics
- Drug Discovery4▲ 30×5 topics
- Genomic Profiling4▲ 56×2 topics
- Medicinal Chemistry4▲ 22×6 topics
- Inflammation4▲ 2.5×11 topics
- ALK Inhibitors3▲ 78×1 topic
- EGFR Mutations3▲ 78×1 topic
- Protein-Protein Interactions3▲ 109×2 topics
- Foldamers3▲ 132×1 topic
- Peptide Synthesis3▲ 132×1 topic
- Enantioselective3▲ 153×2 topics
- Precision Medicine3▲ 7.9×3 topics
- Synthesis3▲ 10×3 topics
- Cetuximab2▲ 41×1 topic
- KRAS Mutations2▲ 108×1 topic
- Oncogenic Mutations2▲ 120×2 topics
- Prognostic Factors2▲ 8.1×4 topics
- Cell Signaling2▲ 21×3 topics
- Mutation2▲ 18×3 topics
- Therapeutic Targets2▲ 20×3 topics
- Amination2▲ 191×1 topic
- Catalytic2▲ 24×1 topic
- Cell Migration2▲ 58×2 topics
- Chiral Ligands2▲ 89×2 topics
- Enantioselective Reactions2▲ 73×2 topics
- Immune Checkpoint Blockade2▲ 24×1 topic
- PD-1 and PD-L12▲ 24×1 topic
- Protein Kinases2▲ 253×1 topic
- Ras Signaling2▲ 253×1 topic
Which research topics does Mirati Therapeutics (United States) publish most on?
By volume in 2022-now: Cancer-related gene regulation, Lung Cancer Treatments and Mutations, Chemical Synthesis and Analysis and Colorectal Cancer Treatments and Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer-related gene regulation Molecular Biology 6 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 3 Chemical Synthesis and Analysis Molecular Biology 3 works
- 4 Colorectal Cancer Treatments and Studies Oncology 2 works
- 5 Synthesis and Catalytic Reactions Organic Chemistry 2 works
- 6 Protein Kinase Regulation and GTPase Signaling Molecular Biology 2 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 8 Biochemical and Molecular Research Molecular Biology 2 works
- 9 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
- 10 Synthetic Organic Chemistry Methods Organic Chemistry 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Mirati Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 203% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Mirati Therapeutics (United States) as a percentage of every work published that year, 0.00040% in 2024.
Fractional works of Mirati Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- Scripps Health
- University of San Diego
- General Atomics (United States)
- UC San Diego Health System
- Alliant International University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Mirati Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
